Open access chemical and clinical probes to support drug discovery.
Edwards AM., Bountra C., Kerr DJ., Willson TM.
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.